Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Relationship Between Gremlin-1 Levels and Wagner Classification inDiabetic Foot Patients and Evaluation of Its Usability as a Biomarker in the Progress toAmputation

NCT06753604 is registered in ClinicalTrials.gov with Seyma Acik as lead sponsor.

NCT NCT06753604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06753604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Relationship Between Gremlin-1 Levels and Wagner Classification inDiabetic Foot Patients and Evaluation of Its Usability as a Biomarker in the Progress toAmputation
Lead sponsor
Seyma Acik
Phase
Observational
Overall status
Completed
Start date
December 20, 2019
Completion date
February 27, 2021
Enrollment
85 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, diabetic foot disease, diabetic foot ulcer, diabetic neuropathy, peripheral arterial disease